BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15245934)

  • 1. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy.
    Wehle MJ; Thiel DD; Petrou SP; Young PR; Frank I; Karsteadt N
    Urology; 2004 Jul; 64(1):49-52. PubMed ID: 15245934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
    Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
    AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy.
    Marshall FM
    J Urol; 2005 Sep; 174(3):868-9. PubMed ID: 16093973
    [No Abstract]   [Full Text] [Related]  

  • 4. Conservative management of small renal tumors.
    Matsuzaki M; Kawano Y; Morikawa H; Shiga Y; Murata H; Komatsu H
    Hinyokika Kiyo; 2007 Apr; 53(4):207-11. PubMed ID: 17515068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
    O'Connor KM; Davis N; Lennon GM; Quinlan DM; Mulvin DW
    BJU Int; 2009 Jun; 103(11):1492-5. PubMed ID: 19076135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management of small renal masses.
    Martínez Rodríguez C; Tardáguila de la Fuente G; Villanueva Campos AM
    Radiologia (Engl Ed); 2020; 62(3):167-179. PubMed ID: 31882171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging-guided radiofrequency ablation of solid renal tumors.
    Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
    AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up.
    Arzola J; Baughman SM; Hernandez J; Bishoff JT
    Urology; 2006 Nov; 68(5):983-7. PubMed ID: 17095059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.
    Permpongkosol S; Link RE; Solomon SB; Kavoussi LR
    J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome.
    Lamb GW; Bromwich EJ; Vasey P; Aitchison M
    Urology; 2004 Nov; 64(5):909-13. PubMed ID: 15533476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Beisland C; Hjelle KM; Reisaeter LA; Bostad L
    Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observation of small incidentally detected renal masses.
    Bosniak MA
    Semin Urol Oncol; 1995 Nov; 13(4):267-72. PubMed ID: 8595550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth characteristics of renal cortical tumors in patients managed by watchful waiting.
    Sowery RD; Siemens DR
    Can J Urol; 2004 Oct; 11(5):2407-10. PubMed ID: 15579229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of renal tumor growth rates determined by using serial volumetric CT measurements.
    Zhang J; Kang SK; Wang L; Touijer A; Hricak H
    Radiology; 2009 Jan; 250(1):137-44. PubMed ID: 19092093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol.
    Tan YK; Best SL; Olweny E; Park S; Trimmer C; Cadeddu JA
    Urology; 2012 Apr; 79(4):827-30. PubMed ID: 22309782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral benign renal oncocytomas and the role of renal biopsy: single institution review.
    Leone AR; Kidd LC; Diorio GJ; Zargar-Shoshtari K; Sharma P; Sexton WJ; Spiess PE
    BMC Urol; 2017 Jan; 17(1):6. PubMed ID: 28081704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small renal oncocytomas: differentiation with multiphase CT.
    Gakis G; Kramer U; Schilling D; Kruck S; Stenzl A; Schlemmer HP
    Eur J Radiol; 2011 Nov; 80(2):274-8. PubMed ID: 20667676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidentally detected small renal masses - investigation and management.
    Rao K; Royce PL
    Aust Fam Physician; 2011 Oct; 40(10):776-82. PubMed ID: 22003479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.